The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
The grant aims to fund research focusing on transgender individuals, particularly the biological and immunological effects of gender reassignment interventions such as hormones, drugs, and surgical procedures. It seeks to understand how these interventions impact the susceptibility of transgender people to HIV and other sexually transmitted infections (STIs). This research is hypothesis-generating and is intended to support the development of effective prevention and treatment strategies for HIV and STIs among the transgender population.